Tag: optical genome mapping market share

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Optical Genome Mapping Market Value Analysis: What Growth Is Expected Over The Forecast Period?

The market for optical genome mapping has experienced remarkable expansion, projecting a rise from $0.23 billion in 2025 to $0.29 billion in 2026, driven by a substantial compound annual growth rate of 29.4%. This preceding period of accelerated growth was spurred by several key factors, including the inherent constraints of next generation sequencing when identifying significant structural variations, augmented financial support for genomic research initiatives, an escalating incidence of hereditary ailments, a heightened need for sophisticated cytogenetic methodologies, and ongoing innovations in imaging technologies and DNA marking techniques.

The field of optical genome mapping is poised for remarkable expansion, projecting a substantial market valuation of $0.74 billion by the year 2030, driven by a compound annual growth rate of 25.9%. This anticipated surge in growth is fueled by several key factors, including the increasing incorporation of optical genome mapping within clinical laboratory settings, a heightened level of investment in precision medicine research and development, the broader acceptance of automated systems for genomic analysis, the widening application of this technology in the study of oncology and blood-related cancers, and the continually decreasing expenses associated with genomic analysis tools. Furthermore, the upcoming period is expected to witness significant trends such as the elevated utilization of optical genome mapping for identifying structural variations in the genome, its growing application in research concerning rare diseases and cancer, an increased demand for genomic analysis that offers high resolution and long reads, the expansion of optical genome mapping’s utility in clinical diagnostic processes, and a growing inclination towards employing optical genome mapping in conjunction with sequencing techniques.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Optical Genome Mapping Market Expansion Drivers: What Is Shaping Future Growth?

The escalating need for personalized medical interventions is anticipated to be a key catalyst for the expansion of the optical genome mapping sector. This personalized medicine strategy aims to tailor treatments and preventive measures based on an individual’s unique genetic composition, lifestyle choices, and environmental factors. Factors fueling this demand include the growing incidence of long-term illnesses, innovations in genetic analysis

Optical Genome Mapping Market Segmentation Trends And Revenue Drivers

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

Optical Genome Mapping Market Strategic Trends: What Is Defining The Next Phase Of Growth?

The optical genome mapping (OGM) market is characterized by leading entities actively pursuing technological improvements, specifically the creation of OGM-based laboratory-developed tests (LDTs) designed for the comprehensive identification of structural variants across the genome. These advancements aim to elevate diagnostic precision, streamline laboratory processes, and lessen the dependence on a variety of conventional cytogenetic methodologies. An OGM-based LDT functions by employing exceptionally long, high-molecular-weight DNA molecules that are tagged with fluorescent markers and aligned within nanochannels. This configuration facilitates high-resolution imaging, enabling the detection of genomic alterations such as insertions, deletions, translocations, and expanded repeat regions capabilities that might be overlooked by short-read sequencing or microarray techniques. Illustrating this, Bionano Laboratories, a U.S.-based subsidiary of Bionano Genomics holding CLIA certification, introduced its OGM Dx Postnatal Whole Genome SV test in March 2023. This test facilitates genome-wide identification of structural variants in individuals affected by developmental disorders, intellectual disabilities, autism spectrum disorders, epilepsy, or previously undiagnosed genetic conditions. By merging high-resolution OGM with variant calling within a unified testing workflow, it diminishes the necessity for multiple traditional cytogenetic analyses, thereby delivering expedited and more thorough diagnostic findings.

Optical Genome Mapping Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Access The Complete Optical Genome Mapping Market Report:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Optical Genome Mapping Market Largest Region By Revenue And Market Share

North Americawas the largest region in the optical genome mapping market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Optical Genome Mapping Market Progress Through 2030?

The optical genome mapping market size has experienced exponential growth in recent years. It is projected to expand from $0.23 billion in 2025 to $0.29 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 29.4%. The expansion observed in the historic period can be ascribed to several factors, including the limitations of next-generation sequencing in detecting large structural variants, increased funding for genomic research, a rising prevalence of genetic disorders, the growing demand for advanced cytogenetic techniques, and technological advancements in imaging and DNA labeling.

The optical genome mapping market size is projected to experience significant expansion in the coming years, reaching $0.74 billion by 2030, driven by a compound annual growth rate (CAGR) of 25.9%. This growth throughout the forecast period is attributable to elements such as the increasing integration of ogm within clinical laboratories, rising investment in precision medicine initiatives, the growing adoption of automated genomic analysis platforms, expanding applications in oncology and hematological malignancies, and the declining costs of genomic analysis technologies. Prominent trends anticipated in the forecast period include the growing uptake of optical genome mapping in structural variant detection, increased utilization of ogm in rare disease and cancer research, a rising demand for high-resolution long-read genomic analysis, the expansion of ogm applications into clinical diagnostics, and a growing preference for the complementary use of ogm alongside sequencing technologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

What Important Drivers Are Powering The Optical Genome Mapping Market Growth?

The burgeoning demand for precision medicine is projected to stimulate the expansion of the optical genome mapping market moving forward. Precision medicine represents a healthcare strategy that tailors medical treatments and preventive measures to an individual’s specific characteristics, such as their genetic makeup, lifestyle, and environment. The impetus for precision medicine’s demand arises from the escalating occurrence of chronic illnesses, breakthroughs in genomic technologies, augmented investment and funding, and patient calls for personalized care. optical genome mapping bolsters the effectiveness of precision medicine by delivering a thorough and precise comprehension of the genomic modifications linked to various diseases. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA sanctioned 16 novel personalized therapies for individuals with rare diseases in 2023, an increase from six in 2022. Thus, the growing need for precision medicine is propelling the growth of the optical genome mapping market.

Which Segment Groups Define The Optical Genome Mapping Market Landscape?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

What Trends Are Influencing The Optical Genome Mapping Market?

Major companies in the optic neuropathy management market are focused on developing advanced therapies, including monoclonal antibody treatment, to gain a competitive edge. Monoclonal antibodies are lab-created proteins engineered to replicate the immune system’s capacity to combat harmful pathogens such as viruses and bacteria. For example, in March 2023, Horizon Therapeutics, an Ireland-based firm, unveiled a new analysis of MRI findings concerning their drug, UPLIZNA (inebilizumab). This analysis indicated that UPLIZNA decreases the occurrence of asymptomatic optic nerve lesions in patients with neuromyelitis optica spectrum disorder (NMOSD). This demonstrates Horizon’s commitment to delivering novel treatments for rare conditions such as NMOSD, gout, and thyroid eye disease. UPLIZNA functions as a monoclonal antibody to treat NMOSD by specifically targeting and eliminating harmful B cells, thereby reducing inflammation and preventing further harm to the central nervous system and optic nerves, which ultimately leads to fewer relapses and aids in vision preservation.

Which Firms Are Competing In The Optical Genome Mapping Market?

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Access The Complete Optical Genome Mapping Market Report:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Which Region Contributes The Most To The Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Optical Genome Mapping Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company

Optic Atrophy Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/optic-atrophy-management-global-market-report

Peripheral Neuropathy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Diabetic Neuropathy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Optical Genome Mapping Market Be By 2030 Compared To Its 2026 Market Size?

The optical genome mapping market has expanded significantly in recent years. This market is projected to increase from $0.23 billion in 2025 to $0.29 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 29.4%. Historically, this growth has been fueled by factors such as the limitations of next generation sequencing in detecting large structural variants, increasing genomic research funding, the rising prevalence of genetic disorders, a growing demand for advanced cytogenetic techniques, and technological advancements in imaging and DNA labeling.

The optical genome mapping market size is projected to experience substantial growth over the coming years. By 2030, it is anticipated to reach $0.74 billion, exhibiting a compound annual growth rate (CAGR) of 25.9%. This expansion during the forecast period is driven by factors such as the increasing incorporation of OGM in clinical laboratories, greater investment in precision medicine programs, a rise in the uptake of automated genomic analysis platforms, broadening applications within oncology and hematological malignancies, and a decrease in the expenses associated with genomic analysis technologies. Key developments expected during this period include the expanding utilization of optical genome mapping for structural variant detection, its growing application in rare disease and cancer research, an escalating demand for high-resolution long-read genomic analysis, the extension of OGM applications into clinical diagnostics, and an increasing inclination towards using OGM in conjunction with sequencing technologies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Which Factors Are Influencing The Growth Of The Optical Genome Mapping Market?

A key factor anticipated to drive the future expansion of the optical genome mapping market is the rising demand for precision medicine. Precision medicine represents a healthcare strategy tailored to individual traits, including genetic composition, lifestyle choices, and environmental factors, for medical treatment and prevention. The need for precision medicine is fueled by several factors: a growing incidence of chronic illnesses, innovations in genomic technologies, greater investment and funding, and patients’ desire for customized care. optical genome mapping boosts the effectiveness of precision medicine by offering a precise and thorough insight into genomic changes linked to diverse diseases. As an illustration, data from February 2024, shared by the US-based non-profit Personalized Medicine Coalition, revealed that the FDA sanctioned 16 new personalized treatments for individuals with rare conditions in 2023, an increase from six in 2022. Consequently, the heightened demand for precision medicine is acting as a catalyst for the growth of the optical genome mapping market.

Which Segments Define The Optical Genome Mapping Market Segment Structure?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

Which Trends Are Influencing Demand In The Optical Genome Mapping Market?

Leading companies in the optical genome mapping (OGM) market are concentrating on developing technological advancements, specifically OGM-based laboratory-developed tests (LDTs) for genome-wide structural variant detection. These efforts aim to enhance diagnostic accuracy, improve workflow efficiency, and lessen dependence on multiple traditional cytogenetic tests. An OGM-based LDT functions by utilizing ultra-long, high-molecular-weight DNA molecules which are fluorescently labeled and then linearized in nanochannels. This method facilitates high-resolution imaging to detect insertions, deletions, translocations, and repeat expansions across the genome, features often overlooked by short-read sequencing or microarrays. For instance, in March 2023, Bionano Laboratories, a U.S.-based CLIA-certified subsidiary of Bionano Genomics, introduced the OGM Dx Postnatal Whole Genome SV test. This product allows for genome-wide detection of structural variants in patients suffering from developmental disorders, intellectual disability, autism spectrum disorder, epilepsy, or undiagnosed genetic conditions. It integrates high-resolution OGM with variant calling in a single-test workflow, thereby reducing the need for numerous classical cytogenetic assays and offering quicker, more comprehensive diagnostic insights.

Who Are The Established Players Within The Optical Genome Mapping Market?

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Get The Full Optical Genome Mapping Market Report:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Which Region Leads The Optical Genome Mapping Market In Overall Market Size?

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Optical Genome Mapping Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company

Optic Atrophy Management Market Report 2026

https://www.thebusinessresearchcompany.com/report/optic-atrophy-management-global-market-report

Peripheral Neuropathy Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Diabetic Neuropathy Market Report

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Optical Genome Mapping Market Expected To Change Between 2026 And 2030?

The optical genome mapping market size has demonstrated rapid expansion in recent years. This market is projected to expand from $0.23 billion in 2025 to $0.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 29.4%. Historically, this expansion has been driven by factors such as the constraints of next generation sequencing in detecting large structural variants, augmented genomic research funding, the escalating prevalence of genetic disorders, the rising demand for advanced cytogenetic techniques, and progress in imaging and DNA labeling technologies.

The optical genome mapping market size is projected to undergo substantial expansion in the coming years. It is anticipated to reach $0.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 25.9%. This projected growth throughout the forecast period stems from factors such as the increasing integration of OGM in clinical laboratories, rising investment in precision medicine initiatives, growing adoption of automated genomic analysis platforms, expanding applications in oncology and hematological malignancies, and the declining costs of genomic analysis technologies. Prominent trends for the forecast period include the growing adoption of optical genome mapping in structural variant detection, increasing use of OGM in rare disease and cancer research, rising demand for high-resolution long-read genomic analysis, the expansion of OGM applications in clinical diagnostics, and a growing preference for the complementary use of OGM with sequencing technologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Which Economic Or Industry Drivers Are Impacting The Optical Genome Mapping Market?

The growing need for precision medicine is anticipated to fuel the expansion of the optical genome mapping market moving ahead. Precision medicine represents a healthcare strategy that tailors medical treatments and preventative measures to unique individual attributes, including genetic composition, lifestyle choices, and environmental factors. The escalating prevalence of chronic illnesses, innovations in genomic technologies, heightened investment and financial backing, and patients’ desire for customized care are all contributing factors to the demand for precision medicine. optical genome mapping improves the effectiveness of precision medicine by offering a thorough and precise comprehension of genomic changes linked to different ailments. An example of this is seen in February 2024, where the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA sanctioned 16 new personalized treatments for individuals with rare conditions in 2023, an increase from six in 2022. Consequently, the escalating need for precision medicine is boosting the expansion of the optical genome mapping market.

How Is The Optical Genome Mapping Market Structured Across Different Segments?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

What Industry Trends Are Redefining The Optical Genome Mapping Market?

Key players in the optical genome mapping (OGM) market are concentrating on creating technological innovations, particularly OGM-based laboratory-developed tests (LDTs), designed for comprehensive genome-wide structural variant identification. This aims to boost diagnostic precision, streamline operational processes, and lessen dependence on numerous conventional cytogenetic analyses. An OGM-based LDT utilizes extremely long, high-molecular-weight DNA molecules, which are fluorescently marked and straightened within nanochannels. This enables high-resolution imaging to detect insertions, deletions, translocations, and repeat expansions throughout the genome, features frequently overlooked by short-read sequencing or microarrays. As an example, in March 2023, Bionano Laboratories, a CLIA-certified U.S. subsidiary of Bionano Genomics, introduced its OGM Dx Postnatal Whole Genome SV test. This product facilitates the detection of structural variants across the entire genome in individuals experiencing developmental disorders, intellectual disability, autism spectrum disorder, epilepsy, or unconfirmed genetic conditions. It combines high-resolution OGM with variant calling within a unified test workflow, thereby minimizing the necessity for multiple traditional cytogenetic assays and offering quicker, more extensive diagnostic understanding.

Which Major Players Dominate The Optical Genome Mapping Market?

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Read the full optical genome mapping market report here:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

What Are The Top-Performing Regions Within The Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Optical Genome Mapping Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company

Optic Atrophy Management Global Market Report

https://www.thebusinessresearchcompany.com/report/optic-atrophy-management-global-market-report

Peripheral Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Diabetic Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Optical Genome Mapping Market Expected To Change Between 2026 And 2030?

The optical genome mapping market size has demonstrated rapid expansion in recent years. This market is projected to expand from $0.23 billion in 2025 to $0.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 29.4%. Historically, this expansion has been driven by factors such as the constraints of next generation sequencing in detecting large structural variants, augmented genomic research funding, the escalating prevalence of genetic disorders, the rising demand for advanced cytogenetic techniques, and progress in imaging and DNA labeling technologies.

The optical genome mapping market size is projected to undergo substantial expansion in the coming years. It is anticipated to reach $0.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 25.9%. This projected growth throughout the forecast period stems from factors such as the increasing integration of OGM in clinical laboratories, rising investment in precision medicine initiatives, growing adoption of automated genomic analysis platforms, expanding applications in oncology and hematological malignancies, and the declining costs of genomic analysis technologies. Prominent trends for the forecast period include the growing adoption of optical genome mapping in structural variant detection, increasing use of OGM in rare disease and cancer research, rising demand for high-resolution long-read genomic analysis, the expansion of OGM applications in clinical diagnostics, and a growing preference for the complementary use of OGM with sequencing technologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Which Economic Or Industry Drivers Are Impacting The Optical Genome Mapping Market?

The growing need for precision medicine is anticipated to fuel the expansion of the optical genome mapping market moving ahead. Precision medicine represents a healthcare strategy that tailors medical treatments and preventative measures to unique individual attributes, including genetic composition, lifestyle choices, and environmental factors. The escalating prevalence of chronic illnesses, innovations in genomic technologies, heightened investment and financial backing, and patients’ desire for customized care are all contributing factors to the demand for precision medicine. optical genome mapping improves the effectiveness of precision medicine by offering a thorough and precise comprehension of genomic changes linked to different ailments. An example of this is seen in February 2024, where the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA sanctioned 16 new personalized treatments for individuals with rare conditions in 2023, an increase from six in 2022. Consequently, the escalating need for precision medicine is boosting the expansion of the optical genome mapping market.

How Is The Optical Genome Mapping Market Structured Across Different Segments?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

What Industry Trends Are Redefining The Optical Genome Mapping Market?

Key players in the optical genome mapping (OGM) market are concentrating on creating technological innovations, particularly OGM-based laboratory-developed tests (LDTs), designed for comprehensive genome-wide structural variant identification. This aims to boost diagnostic precision, streamline operational processes, and lessen dependence on numerous conventional cytogenetic analyses. An OGM-based LDT utilizes extremely long, high-molecular-weight DNA molecules, which are fluorescently marked and straightened within nanochannels. This enables high-resolution imaging to detect insertions, deletions, translocations, and repeat expansions throughout the genome, features frequently overlooked by short-read sequencing or microarrays. As an example, in March 2023, Bionano Laboratories, a CLIA-certified U.S. subsidiary of Bionano Genomics, introduced its OGM Dx Postnatal Whole Genome SV test. This product facilitates the detection of structural variants across the entire genome in individuals experiencing developmental disorders, intellectual disability, autism spectrum disorder, epilepsy, or unconfirmed genetic conditions. It combines high-resolution OGM with variant calling within a unified test workflow, thereby minimizing the necessity for multiple traditional cytogenetic assays and offering quicker, more extensive diagnostic understanding.

Which Major Players Dominate The Optical Genome Mapping Market?

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Read the full optical genome mapping market report here:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

What Are The Top-Performing Regions Within The Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Optical Genome Mapping Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company

Optic Atrophy Management Global Market Report

https://www.thebusinessresearchcompany.com/report/optic-atrophy-management-global-market-report

Peripheral Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Diabetic Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Optical Genome Mapping Market Expected To Change Between 2026 And 2030?

The optical genome mapping market size has demonstrated rapid expansion in recent years. This market is projected to expand from $0.23 billion in 2025 to $0.29 billion in 2026, achieving a compound annual growth rate (CAGR) of 29.4%. Historically, this expansion has been driven by factors such as the constraints of next generation sequencing in detecting large structural variants, augmented genomic research funding, the escalating prevalence of genetic disorders, the rising demand for advanced cytogenetic techniques, and progress in imaging and DNA labeling technologies.

The optical genome mapping market size is projected to undergo substantial expansion in the coming years. It is anticipated to reach $0.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 25.9%. This projected growth throughout the forecast period stems from factors such as the increasing integration of OGM in clinical laboratories, rising investment in precision medicine initiatives, growing adoption of automated genomic analysis platforms, expanding applications in oncology and hematological malignancies, and the declining costs of genomic analysis technologies. Prominent trends for the forecast period include the growing adoption of optical genome mapping in structural variant detection, increasing use of OGM in rare disease and cancer research, rising demand for high-resolution long-read genomic analysis, the expansion of OGM applications in clinical diagnostics, and a growing preference for the complementary use of OGM with sequencing technologies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Which Economic Or Industry Drivers Are Impacting The Optical Genome Mapping Market?

The growing need for precision medicine is anticipated to fuel the expansion of the optical genome mapping market moving ahead. Precision medicine represents a healthcare strategy that tailors medical treatments and preventative measures to unique individual attributes, including genetic composition, lifestyle choices, and environmental factors. The escalating prevalence of chronic illnesses, innovations in genomic technologies, heightened investment and financial backing, and patients’ desire for customized care are all contributing factors to the demand for precision medicine. optical genome mapping improves the effectiveness of precision medicine by offering a thorough and precise comprehension of genomic changes linked to different ailments. An example of this is seen in February 2024, where the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA sanctioned 16 new personalized treatments for individuals with rare conditions in 2023, an increase from six in 2022. Consequently, the escalating need for precision medicine is boosting the expansion of the optical genome mapping market.

How Is The Optical Genome Mapping Market Structured Across Different Segments?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

What Industry Trends Are Redefining The Optical Genome Mapping Market?

Key players in the optical genome mapping (OGM) market are concentrating on creating technological innovations, particularly OGM-based laboratory-developed tests (LDTs), designed for comprehensive genome-wide structural variant identification. This aims to boost diagnostic precision, streamline operational processes, and lessen dependence on numerous conventional cytogenetic analyses. An OGM-based LDT utilizes extremely long, high-molecular-weight DNA molecules, which are fluorescently marked and straightened within nanochannels. This enables high-resolution imaging to detect insertions, deletions, translocations, and repeat expansions throughout the genome, features frequently overlooked by short-read sequencing or microarrays. As an example, in March 2023, Bionano Laboratories, a CLIA-certified U.S. subsidiary of Bionano Genomics, introduced its OGM Dx Postnatal Whole Genome SV test. This product facilitates the detection of structural variants across the entire genome in individuals experiencing developmental disorders, intellectual disability, autism spectrum disorder, epilepsy, or unconfirmed genetic conditions. It combines high-resolution OGM with variant calling within a unified test workflow, thereby minimizing the necessity for multiple traditional cytogenetic assays and offering quicker, more extensive diagnostic understanding.

Which Major Players Dominate The Optical Genome Mapping Market?

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Read the full optical genome mapping market report here:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

What Are The Top-Performing Regions Within The Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Optical Genome Mapping Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company

Optic Atrophy Management Global Market Report

https://www.thebusinessresearchcompany.com/report/optic-atrophy-management-global-market-report

Peripheral Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Diabetic Neuropathy Global Market Report

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the optical genome mapping market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Optical Genome Mapping Market covering 2026–2035?

The market size for optical genome mapping has expanded significantly in recent years. It is projected to increase from $0.23 billion in 2025 to $0.29 billion in 2026, registering a compound annual growth rate (CAGR) of 29.4%. Historically, this growth has been fueled by factors such as the limitations of next generation sequencing in detecting large structural variants, a rise in genomic research funding, the increasing prevalence of genetic disorders, a growing demand for advanced cytogenetic techniques, and technological advancements in imaging and DNA labeling.

The optical genome mapping market is projected to experience substantial expansion over the next few years. It is expected to achieve a market size of $0.74 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 25.9%. This anticipated growth during the forecast period stems from several factors, including the increasing integration of optical genome mapping (OGM) into clinical laboratories, rising investments in precision medicine initiatives, the growing adoption of automated genomic analysis platforms, expanding applications in oncology and hematological malignancies, and the declining costs associated with genomic analysis technologies. Prominent trends observed for this period encompass the growing adoption of optical genome mapping in structural variant detection, its increased utilization in rare disease and cancer research, a rising demand for high-resolution long-read genomic analysis, the expansion of OGM applications within clinical diagnostics, and a growing preference for the complementary use of OGM alongside sequencing technologies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Optical Genome Mapping Market?

The rising demand for precision medicine is anticipated to fuel the expansion of the optical genome mapping market moving forward. Precision medicine represents a healthcare approach that tailors medical treatments and prevention strategies to individual characteristics such as genetic makeup, lifestyle, and environment. The need for precision medicine is propelled by factors including the increasing prevalence of chronic diseases, breakthroughs in genomic technologies, rising investment and funding, and patient desire for personalized care. optical genome mapping enhances the effectiveness of precision medicine by delivering a comprehensive and precise understanding of genomic alterations linked to various diseases. For instance, in February 2024, as per the Personalized Medicine Coalition, a US-based non-profit organization, the FDA sanctioned 16 new personalized therapies for patients with rare diseases in 2023, an increase from six in 2022. Thus, the growing requirement for precision medicine is driving the growth of the optical genome mapping market.

What Segments Are Identified Within The Structure Of The Optical Genome Mapping Market?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

Which Market Trends Are Opening Growth Opportunities In The Optical Genome Mapping Market?

Leading companies in the optical genome mapping (OGM) market are primarily focused on advancing technology, such as developing OGM-based laboratory-developed tests (LDTs) for genome-wide structural variant detection, with the goals of improving diagnostic accuracy, increasing workflow efficiency, and reducing the need for multiple traditional cytogenetic tests. An OGM-based LDT operates by using ultra-long, high-molecular-weight DNA molecules, which are fluorescently labeled and then linearized in nanochannels, enabling high-resolution imaging. This allows for the identification of insertions, deletions, translocations, and repeat expansions across the genome, capabilities often missed by short-read sequencing or microarrays. For example, in March 2023, Bionano Laboratories, a CLIA-certified U.S. subsidiary of Bionano Genomics, introduced the OGM Dx Postnatal Whole Genome SV test. This product facilitates genome-wide detection of structural variants in patients experiencing developmental disorders, intellectual disability, autism spectrum disorder, epilepsy, or undiagnosed genetic conditions. It integrates high-resolution OGM with variant calling within a single-test workflow, thereby minimizing the necessity for multiple classical cytogenetic assays and providing more rapid, comprehensive diagnostic insights.

Which Key Market Players Are Investing In Expansion And Innovation Within The Optical Genome Mapping Market?

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Which Regions Are Projected To Dominate The Optical Genome Mapping Market In The Coming Years?

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Optical Genome Mapping Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Digital Genome Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-genome-global-market-report

Optical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/optical-imaging-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model